메뉴 건너뛰기




Volumn 2013, Issue 8, 2013, Pages

Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; GEMCITABINE; IRINOTECAN; PACLITAXEL; VINORELBINE TARTRATE; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE;

EID: 84893422070     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009256.pub2     Document Type: Review
Times cited : (111)

References (44)
  • 1
    • 0036923412 scopus 로고    scopus 로고
    • Comparison of efficacy and toxicity between gemcitabine plus carboplatin and gemcitabine plus cisplatin in the treatment of advanced non-small cell lung cancer
    • Cai X, Chen P, Yin X, Li Q. Comparison of efficacy and toxicity between gemcitabine plus carboplatin and gemcitabine plus cisplatin in the treatment of advanced non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 2002;5(6):427-8.
    • (2002) Zhongguo Fei Ai Za Zhi , vol.5 , Issue.6 , pp. 427-428
    • Cai, X.1    Chen, P.2    Yin, X.3    Li, Q.4
  • 2
    • 34247855822 scopus 로고    scopus 로고
    • A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly
    • Chen YM, Perng RP, Tsai CM, Whang-Peng J. A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly. Journal of Thoracic Oncology 2006;1(2):141-5.
    • (2006) Journal of Thoracic Oncology , vol.1 , Issue.2 , pp. 141-145
    • Chen, Y.M.1    Perng, R.P.2    Tsai, C.M.3    Whang-Peng, J.4
  • 3
    • 84857376291 scopus 로고    scopus 로고
    • British Thoracic Oncology Group Trial, BTOG2: Randomised phase III clinical trial of gemcitabine (1250mg/msup2/sup) combined with cisplatin 50 mg/msup2/sup (GC50) versus cisplatin 80 mg/msup2/sup (GC80) versus carboplatin AUC 6 (GCb6) in advanced NSCLC
    • Ferry D, Billingham L, Jarrett H, Dunlop D, Thompson J, Kumar M, et al. British Thoracic Oncology Group Trial, BTOG2: Randomised phase III clinical trial of gemcitabine (1250mg/msup2/sup) combined with cisplatin 50 mg/msup2/sup (GC50) versus cisplatin 80 mg/msup2/sup (GC80) versus carboplatin AUC 6 (GCb6) in advanced NSCLC. Thorax 2011;66:A41.
    • (2011) Thorax , vol.66 , pp. 41
    • Ferry, D.1    Billingham, L.2    Jarrett, H.3    Dunlop, D.4    Thompson, J.5    Kumar, M.6
  • 4
    • 0042413836 scopus 로고    scopus 로고
    • Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group
    • Fossella F, Pereira JR, von Pawel J, Pluzanska A, Gorbounova V, Kaukel E, et al. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group. Journal of Clinical Oncology 2003;21(16):3016-24.
    • (2003) Journal of Clinical Oncology , vol.21 , Issue.16 , pp. 3016-3024
    • Fossella, F.1    Pereira, J.R.2    von Pawel, J.3    Pluzanska, A.4    Gorbounova, V.5    Kaukel, E.6
  • 5
    • 0038460705 scopus 로고    scopus 로고
    • Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer
    • Mazzanti P, Massacesi C, Rocchi MB, Mattioli R, Lippe P, Trivisonne R, et al. Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer. Lung Cancer 2003;41(1):81-9.
    • (2003) Lung Cancer , vol.41 , Issue.1 , pp. 81-89
    • Mazzanti, P.1    Massacesi, C.2    Rocchi, M.B.3    Mattioli, R.4    Lippe, P.5    Trivisonne, R.6
  • 6
    • 0036810227 scopus 로고    scopus 로고
    • Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial
    • Rosell R, Gatzemeier U, Betticher DC, Keppler U, Macha HN, Pirker R, et al. Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. Annals of Oncology 2002;13(10):1539-49.
    • (2002) Annals of Oncology , vol.13 , Issue.10 , pp. 1539-1549
    • Rosell, R.1    Gatzemeier, U.2    Betticher, D.C.3    Keppler, U.4    Macha, H.N.5    Pirker, R.6
  • 8
    • 0035889915 scopus 로고    scopus 로고
    • Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a phase II trial in patients with metastatic nonsmall cell lung carcinoma
    • Sweeney CJ, Zhu J, Sandler AB, Schiller J, Belani CP, Langer C, et al. Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a phase II trial in patients with metastatic nonsmall cell lung carcinoma. Cancer 2001;92(10):2639-47.
    • (2001) Cancer , vol.92 , Issue.10 , pp. 2639-2647
    • Sweeney, C.J.1    Zhu, J.2    Sandler, A.B.3    Schiller, J.4    Belani, C.P.5    Langer, C.6
  • 9
    • 85041838981 scopus 로고    scopus 로고
    • A randomized phase II trial of paclitaxel in combination chemotherapy with platinum in the treatment of non-small cell lung cancer
    • Yan D, Wang G, Zhang G, Hu C. A randomized phase II trial of paclitaxel in combination chemotherapy with platinum in the treatment of non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 2001;4(3):188-90.
    • (2001) Zhongguo Fei Ai Za Zhi , vol.4 , Issue.3 , pp. 188-190
    • Yan, D.1    Wang, G.2    Zhang, G.3    Hu, C.4
  • 10
    • 0042661285 scopus 로고    scopus 로고
    • Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial
    • Zatloukal P, Petruzelka L, Zemanová M, Kolek V, Skricková J, Pesek M, et al. Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial. Lung Cancer 2003;41(3):321-31.
    • (2003) Lung Cancer , vol.41 , Issue.3 , pp. 321-331
    • Zatloukal, P.1    Petruzelka, L.2    Zemanová, M.3    Kolek, V.4    Skricková, J.5    Pesek, M.6
  • 11
    • 0034978657 scopus 로고    scopus 로고
    • Phase III randomized trial of docetaxel in combination with cisplatin or carboplatin or vinorelbine plus cisplatin in advanced non-small cell lung cancer: interim analysis
    • Belani C, TAX 326 Study Group. Phase III randomized trial of docetaxel in combination with cisplatin or carboplatin or vinorelbine plus cisplatin in advanced non-small cell lung cancer: interim analysis. Seminars in Oncology 2001;28(3):10-4.
    • (2001) Seminars in Oncology , vol.28 , Issue.3 , pp. 10-14
    • Belani, C.1
  • 12
    • 0036333477 scopus 로고    scopus 로고
    • Docetaxel in combination with platinums (cisplatin or carboplatin) in advanced and metastatic non-small cell lung cancer
    • Belani CP, TAX 326 Study Group. Docetaxel in combination with platinums (cisplatin or carboplatin) in advanced and metastatic non-small cell lung cancer. Seminars in Oncology 2002;29(3):4-9.
    • (2002) Seminars in Oncology , vol.29 , Issue.3 , pp. 4-9
    • Belani, C.P.1
  • 13
    • 33745893529 scopus 로고    scopus 로고
    • Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial
    • Belani CP, Pereira JR, von Pawel J, Pluzanska A, Gorbounova V, Kaukel E, et al. Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial. Lung Cancer 2006;53(2):231-9.
    • (2006) Lung Cancer , vol.53 , Issue.2 , pp. 231-239
    • Belani, C.P.1    Pereira, J.R.2    von Pawel, J.3    Pluzanska, A.4    Gorbounova, V.5    Kaukel, E.6
  • 14
    • 0000845015 scopus 로고    scopus 로고
    • Docetaxel + cisplatin (DC) and docetaxel + carboplatin (DCb) versus vinorelbine + cisplatin (VC) in chemotherapy-naive patients with advanced and metastatic non-small cell lung cancer (NSCLC): results of a multicenter, randomized phase III study
    • Fossella F. Docetaxel + cisplatin (DC) and docetaxel + carboplatin (DCb) versus vinorelbine + cisplatin (VC) in chemotherapy-naive patients with advanced and metastatic non-small cell lung cancer (NSCLC): results of a multicenter, randomized phase III study. European Journal of Cancer 2001;37:S154.
    • (2001) European Journal of Cancer , vol.37 , pp. S154
    • Fossella, F.1
  • 15
    • 0000905275 scopus 로고    scopus 로고
    • Randomized pan-European trial comparing paclitaxel (TAX)/carboplatin (CAR) versus paclitaxel/cisplatin (CIS) in advanced non-small cell lung cancer (NSCLC)
    • Gatzemeier U, Rosell R, Betticher D, Keppler U, Macha H, Pirker R, et al. Randomized pan-European trial comparing paclitaxel (TAX)/carboplatin (CAR) versus paclitaxel/cisplatin (CIS) in advanced non-small cell lung cancer (NSCLC). European Journal of Cancer 1999;35(4):S246.
    • (1999) European Journal of Cancer , vol.35 , Issue.4 , pp. S246
    • Gatzemeier, U.1    Rosell, R.2    Betticher, D.3    Keppler, U.4    Macha, H.5    Pirker, R.6
  • 16
    • 85041857526 scopus 로고    scopus 로고
    • Randomized multicenter trial comparing paclitaxel (TAX)/carboplatin (CAR) versus paclitaxel/cisplatin (CIS) in advanced non-small cell lung cancer (NSCLC): results of a planned interim analysis
    • (abstract 1789)
    • Macha HN, Gatzemeier U, Betticher DC, Keppler U, Berthet P, Chemaissan A, et al. Randomized multicenter trial comparing paclitaxel (TAX)/carboplatin (CAR) versus paclitaxel/cisplatin (CIS) in advanced non-small cell lung cancer (NSCLC): results of a planned interim analysis. Proceedings of the American Society of Clinical Oncology. Los Angeles, 1998; Vol. 17:465a (abstract 1789).
    • (1998) Proceedings of the American Society of Clinical Oncology. Los Angeles , vol.465 , pp. 17
    • Macha, H.N.1    Gatzemeier, U.2    Betticher, D.C.3    Keppler, U.4    Berthet, P.5    Chemaissan, A.6
  • 19
    • 0003268464 scopus 로고    scopus 로고
    • Gemcitabine plus cisplatin (GCis) versus gemcitabine plus carboplatin (GCarb) in patients with stage IIIB and IV non-small lung cancer (NSCLC): final results of Czech Lung Cancer Co-operative Group phase III randomized trial
    • abstract
    • Novakova L, Petruzelka L, Zemanova M, Kolek V, Grygarkova I, Sixtova D, et al. Gemcitabine plus cisplatin (GCis) versus gemcitabine plus carboplatin (GCarb) in patients with stage IIIB and IV non-small lung cancer (NSCLC): final results of Czech Lung Cancer Co-operative Group phase III randomized trial. Proceedings of the American Society of Clinical Oncology. 2002; Vol. 21 Part 1:abstract 1225.
    • (2002) Proceedings of the American Society of Clinical Oncology , vol.21 , pp. 1225
    • Novakova, L.1    Petruzelka, L.2    Zemanova, M.3    Kolek, V.4    Grygarkova, I.5    Sixtova, D.6
  • 20
    • 34250731320 scopus 로고    scopus 로고
    • Results of Polish medical centres within an international randomized phase III study of docetaxel plus cisplatin and docetaxel plus carboplatin versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer
    • Ramlau R, Pluzanska A, Szczesna A, Karnicka-Mlodkowska H, Wojtukiewicz M, Oklek K, et al. Results of Polish medical centres within an international randomized phase III study of docetaxel plus cisplatin and docetaxel plus carboplatin versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer. Journal of Oncology 2007;57(2):146-52.
    • (2007) Journal of Oncology , vol.57 , Issue.2 , pp. 146-152
    • Ramlau, R.1    Pluzanska, A.2    Szczesna, A.3    Karnicka-Mlodkowska, H.4    Wojtukiewicz, M.5    Oklek, K.6
  • 21
    • 0000012871 scopus 로고    scopus 로고
    • A multicenter, randomized phase III study of docetaxel + cisplatin (DC) and docetaxel + carboplatin (DCB) vs. vinorelbine + cisplatin (VC) in chemotherapy-naive patients with advanced and metastatic non-small cell lung cancer
    • Rodriguez J, Pawel J, Pluzanska A, Gorbounova V, Fossella F, Kaukel E, et al. A multicenter, randomized phase III study of docetaxel + cisplatin (DC) and docetaxel + carboplatin (DCB) vs. vinorelbine + cisplatin (VC) in chemotherapy-naive patients with advanced and metastatic non-small cell lung cancer. Proceedings of the American Society of Clinical Oncology. 2001; Vol. 20:314a.
    • (2001) Proceedings of the American Society of Clinical Oncology , vol.20 , pp. 314
    • Rodriguez, J.1    Pawel, J.2    Pluzanska, A.3    Gorbounova, V.4    Fossella, F.5    Kaukel, E.6
  • 22
    • 85041814497 scopus 로고    scopus 로고
    • Cancer facts & figures 2010
    • (accessed 26 June
    • American Cancer Society. Cancer facts & figures 2010. www.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-and-figures-2010 (accessed 26 June 2013).
    • (2013)
  • 23
    • 34347379142 scopus 로고    scopus 로고
    • Cisplatin versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis
    • Ardizzoni A, Boni L, Tiseo M, Fossella FV, Schiller JH, Paesmans M, et al. Cisplatin versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis. Journal of the National Cancer Institute 2007;99(11):847-57.
    • (2007) Journal of the National Cancer Institute , vol.99 , Issue.11 , pp. 847-857
    • Ardizzoni, A.1    Boni, L.2    Tiseo, M.3    Fossella, F.V.4    Schiller, J.H.5    Paesmans, M.6
  • 24
    • 74949133978 scopus 로고    scopus 로고
    • American Society of Clinical Oncology clinical practice guideline: update on chemotherapy for stage IV non-small-cell lung cancer
    • Azzoli CG, Baker S Jr, Temin S, Pao W, AliffT, Brahmer J, et al. American Society of Clinical Oncology clinical practice guideline: update on chemotherapy for stage IV non-small-cell lung cancer. Journal of Clinical Oncology 2009;27(36):6251-66.
    • (2009) Journal of Clinical Oncology , vol.27 , Issue.36 , pp. 6251-6266
    • Azzoli, C.G.1    Baker, S.2    Temin, S.3    Pao, W.4    Aliff, T.5    Brahmer, J.6
  • 25
    • 34548436008 scopus 로고    scopus 로고
    • Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis
    • Baggstrom M, Stinchcombe T, Fried D, Poole C, Hensing T, Socinski M. Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis. Journal of Thoracic Oncology 2007;2(9):845-53.
    • (2007) Journal of Thoracic Oncology , vol.2 , Issue.9 , pp. 845-853
    • Baggstrom, M.1    Stinchcombe, T.2    Fried, D.3    Poole, C.4    Hensing, T.5    Socinski, M.6
  • 26
  • 28
    • 33750603100 scopus 로고    scopus 로고
    • Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database
    • Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. Journal of Clinical Oncology 2006;24(28):4539-44.
    • (2006) Journal of Clinical Oncology , vol.24 , Issue.28 , pp. 4539-4544
    • Govindan, R.1    Page, N.2    Morgensztern, D.3    Read, W.4    Tierney, R.5    Vlahiotis, A.6
  • 30
    • 84872417999 scopus 로고    scopus 로고
    • Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated September 2011
    • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated September 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
    • (2011) The Cochrane Collaboration
    • Higgins, J.P.T.1    Green, S.2
  • 31
    • 5444235920 scopus 로고    scopus 로고
    • Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer
    • Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M. Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer. Journal of Clinical Oncology 2004;22(19):3852-9.
    • (2004) Journal of Clinical Oncology , vol.22 , Issue.19 , pp. 3852-3859
    • Hotta, K.1    Matsuo, K.2    Ueoka, H.3    Kiura, K.4    Tabata, M.5    Tanimoto, M.6
  • 32
    • 34548022868 scopus 로고    scopus 로고
    • A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer
    • Jiang J, Liang X, Zhou X, Huang R, Chu Z. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer. Lung Cancer 2007;57(3):348-58.
    • (2007) Lung Cancer , vol.57 , Issue.3 , pp. 348-358
    • Jiang, J.1    Liang, X.2    Zhou, X.3    Huang, R.4    Chu, Z.5
  • 33
    • 85041843347 scopus 로고    scopus 로고
    • Common toxicity criteria
    • (accessed 26 June
    • National Cancer Institute. Common toxicity criteria. ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcv20_4-30-992.pdf (accessed 26 June 2013).
    • (2013) National Cancer Institute
  • 34
    • 84971581087 scopus 로고
    • Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
    • NSCLC Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995;311(7010):899-909.
    • (1995) BMJ , vol.311 , Issue.7010 , pp. 899-909
  • 35
    • 9144243571 scopus 로고    scopus 로고
    • Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial
    • Paccagnella A, Favaretto A, Oniga F, Barbieri F, Ceresoli G, Torri W, et al. Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial. Lung Cancer 2004;43(1):83-91.
    • (2004) Lung Cancer , vol.43 , Issue.1 , pp. 83-91
    • Paccagnella, A.1    Favaretto, A.2    Oniga, F.3    Barbieri, F.4    Ceresoli, G.5    Torri, W.6
  • 36
    • 0032583387 scopus 로고    scopus 로고
    • Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
    • Parmar MKB, Valter T, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17:2815-34.
    • (1998) Statistics in Medicine , vol.17 , pp. 2815-2834
    • Parmar, M.K.B.1    Valter, T.2    Stewart, L.3
  • 37
    • 0016799829 scopus 로고
    • Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial
    • Pocock S, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975;31:103-15.
    • (1975) Biometrics , vol.31 , pp. 103-115
    • Pocock, S.1    Simon, R.2
  • 38
    • 77951473661 scopus 로고    scopus 로고
    • Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)
    • Reck M, von Pawel J, Zatloukal P, Ramlau R, Gorbounova V, Hirsh V, et al. Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL). Annals of Oncology 2010;21(9):1804-9.
    • (2010) Annals of Oncology , vol.21 , Issue.9 , pp. 1804-1809
    • Reck, M.1    von Pawel, J.2    Zatloukal, P.3    Ramlau, R.4    Gorbounova, V.5    Hirsh, V.6
  • 39
    • 85041800343 scopus 로고    scopus 로고
    • Pharmacology of cancer chemotherapy
    • In: DeVita VT, Lawrence TS, Rosenberg SA editor(s). 7th Edition. Philadelphia: Lippincott Williams & Wilkins
    • Reed E. Pharmacology of cancer chemotherapy. In: DeVita VT, Lawrence TS, Rosenberg SA editor(s). Cancer: Principles and Practice of Oncology. 7th Edition. Philadelphia: Lippincott Williams & Wilkins, 2005:419-26.
    • (2005) Cancer: Principles and Practice of Oncology , pp. 419-426
    • Reed, E.1
  • 40
    • 84870318976 scopus 로고    scopus 로고
    • Review Manager
    • 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration
    • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager. 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
    • (2011)
  • 42
    • 49049089802 scopus 로고    scopus 로고
    • Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
    • Scagliotti V, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. Journal of Clinical Oncology 2008;26:3543-51.
    • (2008) Journal of Clinical Oncology , vol.26 , pp. 3543-3551
    • Scagliotti, V.1    Parikh, P.2    von Pawel, J.3    Biesma, B.4    Vansteenkiste, J.5    Manegold, C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.